Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oriol, A
Right arrow Articles by Esteve, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oriol, A
Right arrow Articles by Esteve, J
Haematologica, Vol 90, Issue 7, 990-992
Copyright © 2005 by Ferrata Storti Foundation

Letter

Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study

A Oriol, JM Ribera, S Brunet, E del Potro, E Abella, and J Esteve

Short, intensive cycles of chemotherapy have resulted in improved survival in BurkittOs lymphoma/leukemia (BL) in adults. The prognosis of patients with immunodeficiency virus (HIV)-associated BL is considered to be poor, but these patients have seldom been treated with BL-specific protocols. However, a study (PETHEMA-LAL3/97) in which patients with BL were treated regardless of their HIV status failed to find differences between HIV-infected and immunocompetent individuals. Furthermore, patients who received highly active antiretroviral therapy (HAART) seemed to have a slightly better disease-free survival than those who did not (p=0.051). We extended the follow-up analysis to elucidate the role of HAART in the survival of HIV-infected patients included in the PETHEMA-LAL3/97 protocol.


This article has been cited by other articles:


Home page
 Ann OncolHome page
A Torresin, M Feasi, and G Cassola
Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?
Ann. Onc., August 1, 2007; 18(8): 1422 - 1423.
[Full Text] [PDF]

Home page
 haematolHome page
B. Xicoy, J.-M. Ribera, P. Miralles, J. Berenguer, R. Rubio, B. Mahillo, M.-E. Valencia, E. Abella, A. Lopez-Guillermo, A. Sureda, et al.
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma
Haematologica, February 1, 2007; 92(2): 191 - 198.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.